Status:
COMPLETED
Community-based Hepatitis B Interventions for Hmong Adults
Lead Sponsor:
University of California, Davis
Collaborating Sponsors:
National Institutes of Health (NIH)
National Cancer Institute (NCI)
Conditions:
Liver Cancer
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
The purpose of this study is to design an intervention to increase hepatitis B (HBV) screening among Hmong Americans.
Detailed Description
The investigators will design an intervention to measure the baseline proportion of Hmong adults (ages 18-64) that have been serologically tested for Hepatitis B. Investigators will work with lay heal...
Eligibility Criteria
Inclusion
- Ages 18-64 years
- Hmong ancestry
- Never have been tested for Hepatitis B
Exclusion
- Children under the age of 18 years
- Adults over the age of 64 years
- Non-Hmong ancestry
- Previous testing of Hepatitis B
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT00888407
Start Date
September 1 2006
End Date
August 1 2011
Last Update
May 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UC Davis Cancer Center
Sacramento, California, United States, 95817